vs

Side-by-side financial comparison of NEOGENOMICS INC (NEO) and TheRealReal, Inc. (REAL). Click either name above to swap in a different company.

TheRealReal, Inc. is the larger business by last-quarter revenue ($194.1M vs $186.7M, roughly 1.0× NEOGENOMICS INC). On growth, TheRealReal, Inc. posted the faster year-over-year revenue change (18.3% vs 11.1%). Over the past eight quarters, TheRealReal, Inc.'s revenue compounded faster (16.2% CAGR vs 6.5%).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

The RealReal, Inc. is an online marketplace for users to buy and sell luxury goods that are authenticated by experts. It has more than 38 million members, and has sold nearly 40 million items as of Sept. 30, 2023.

NEO vs REAL — Head-to-Head

Bigger by revenue
REAL
REAL
1.0× larger
REAL
$194.1M
$186.7M
NEO
Growing faster (revenue YoY)
REAL
REAL
+7.2% gap
REAL
18.3%
11.1%
NEO
Faster 2-yr revenue CAGR
REAL
REAL
Annualised
REAL
16.2%
6.5%
NEO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NEO
NEO
REAL
REAL
Revenue
$186.7M
$194.1M
Net Profit
$-108.0M
Gross Margin
43.3%
74.8%
Operating Margin
46.9%
3.2%
Net Margin
-57.9%
Revenue YoY
11.1%
18.3%
Net Profit YoY
42.0%
EPS (diluted)
$-0.13
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEO
NEO
REAL
REAL
Q1 26
$186.7M
Q4 25
$190.2M
$194.1M
Q3 25
$187.8M
$173.6M
Q2 25
$181.3M
$165.2M
Q1 25
$168.0M
$160.0M
Q4 24
$172.0M
$164.0M
Q3 24
$167.8M
$147.8M
Q2 24
$164.5M
$144.9M
Net Profit
NEO
NEO
REAL
REAL
Q1 26
$-108.0M
Q4 25
Q3 25
$-27.1M
$-54.1M
Q2 25
$-45.1M
$-11.4M
Q1 25
$-25.9M
$62.4M
Q4 24
Q3 24
$-17.7M
$-17.9M
Q2 24
$-18.6M
$-16.7M
Gross Margin
NEO
NEO
REAL
REAL
Q1 26
43.3%
Q4 25
43.8%
74.8%
Q3 25
42.8%
74.3%
Q2 25
42.6%
74.3%
Q1 25
43.6%
75.0%
Q4 24
44.9%
74.4%
Q3 24
44.6%
74.9%
Q2 24
44.1%
74.1%
Operating Margin
NEO
NEO
REAL
REAL
Q1 26
46.9%
Q4 25
-7.1%
3.2%
Q3 25
-14.4%
-4.3%
Q2 25
-26.3%
-6.0%
Q1 25
-16.6%
-8.0%
Q4 24
-10.7%
-3.1%
Q3 24
-12.6%
-9.9%
Q2 24
-13.3%
-13.0%
Net Margin
NEO
NEO
REAL
REAL
Q1 26
-57.9%
Q4 25
Q3 25
-14.4%
-31.1%
Q2 25
-24.9%
-6.9%
Q1 25
-15.4%
39.0%
Q4 24
Q3 24
-10.5%
-12.1%
Q2 24
-11.3%
-11.5%
EPS (diluted)
NEO
NEO
REAL
REAL
Q1 26
$-0.13
Q4 25
$0.06
Q3 25
$-0.49
Q2 25
$-0.13
Q1 25
$-0.14
Q4 24
$-0.57
Q3 24
$-0.17
Q2 24
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEO
NEO
REAL
REAL
Cash + ST InvestmentsLiquidity on hand
$146.1M
$151.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$828.8M
$-415.5M
Total Assets
$1.3B
$409.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEO
NEO
REAL
REAL
Q1 26
$146.1M
Q4 25
$159.6M
$151.2M
Q3 25
$164.1M
$108.4M
Q2 25
$154.7M
$94.3M
Q1 25
$346.2M
$139.6M
Q4 24
$367.0M
$172.2M
Q3 24
$362.0M
$153.2M
Q2 24
$355.1M
$150.7M
Total Debt
NEO
NEO
REAL
REAL
Q1 26
Q4 25
$341.9M
Q3 25
Q2 25
Q1 25
Q4 24
$541.1M
Q3 24
Q2 24
Stockholders' Equity
NEO
NEO
REAL
REAL
Q1 26
$828.8M
Q4 25
$836.6M
$-415.5M
Q3 25
$838.3M
$-385.1M
Q2 25
$854.0M
$-338.2M
Q1 25
$888.3M
$-336.1M
Q4 24
$902.3M
$-407.4M
Q3 24
$908.2M
$-345.4M
Q2 24
$915.9M
$-335.3M
Total Assets
NEO
NEO
REAL
REAL
Q1 26
$1.3B
Q4 25
$1.4B
$409.0M
Q3 25
$1.4B
$366.2M
Q2 25
$1.4B
$349.4M
Q1 25
$1.6B
$400.4M
Q4 24
$1.6B
$423.1M
Q3 24
$1.6B
$406.3M
Q2 24
$1.6B
$407.4M
Debt / Equity
NEO
NEO
REAL
REAL
Q1 26
Q4 25
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEO
NEO
REAL
REAL
Operating Cash FlowLast quarter
$-8.1M
$49.5M
Free Cash FlowOCF − Capex
$45.8M
FCF MarginFCF / Revenue
23.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$18.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEO
NEO
REAL
REAL
Q1 26
$-8.1M
Q4 25
$1.3M
$49.5M
Q3 25
$8.9M
$19.3M
Q2 25
$20.3M
$-3.6M
Q1 25
$-25.3M
$-28.3M
Q4 24
$9.8M
$28.0M
Q3 24
$9.2M
$9.1M
Q2 24
$13.9M
$-6.8M
Free Cash Flow
NEO
NEO
REAL
REAL
Q1 26
Q4 25
$-6.5M
$45.8M
Q3 25
$570.0K
$16.9M
Q2 25
$14.0M
$-11.4M
Q1 25
$-29.8M
$-33.0M
Q4 24
$-1.8M
$22.9M
Q3 24
$-1.6M
$5.0M
Q2 24
$814.0K
$-9.8M
FCF Margin
NEO
NEO
REAL
REAL
Q1 26
Q4 25
-3.4%
23.6%
Q3 25
0.3%
9.7%
Q2 25
7.7%
-6.9%
Q1 25
-17.8%
-20.6%
Q4 24
-1.0%
14.0%
Q3 24
-0.9%
3.4%
Q2 24
0.5%
-6.7%
Capex Intensity
NEO
NEO
REAL
REAL
Q1 26
Q4 25
4.1%
1.9%
Q3 25
4.4%
1.4%
Q2 25
3.5%
4.7%
Q1 25
2.7%
2.9%
Q4 24
6.7%
3.1%
Q3 24
6.4%
2.7%
Q2 24
8.0%
2.1%
Cash Conversion
NEO
NEO
REAL
REAL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
-0.45×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NEO
NEO

Segment breakdown not available.

REAL
REAL

Services$149.0M77%
Products$27.2M14%
Shipping And Handling$17.8M9%

Related Comparisons